These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 19344899)

  • 1. The -1131T>C SNP of the APOA5 gene modulates response to fenofibrate treatment in patients with the metabolic syndrome: a postprandial study.
    Cardona F; Guardiola M; Queipo-Ortuño MI; Murri M; Ribalta J; Tinahones FJ
    Atherosclerosis; 2009 Sep; 206(1):148-52. PubMed ID: 19344899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fenofibrate effect on triglyceride and postprandial response of apolipoprotein A5 variants: the GOLDN study.
    Lai CQ; Arnett DK; Corella D; Straka RJ; Tsai MY; Peacock JM; Adiconis X; Parnell LD; Hixson JE; Province MA; Ordovas JM
    Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1417-25. PubMed ID: 17431185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between glucokinase regulatory protein (GCKR) and apolipoprotein A5 (APOA5) gene polymorphisms and triacylglycerol concentrations in fasting, postprandial, and fenofibrate-treated states.
    Perez-Martinez P; Corella D; Shen J; Arnett DK; Yiannakouris N; Tai ES; Orho-Melander M; Tucker KL; Tsai M; Straka RJ; Province M; Kai CS; Perez-Jimenez F; Lai CQ; Lopez-Miranda J; Guillen M; Parnell LD; Borecki I; Kathiresan S; Ordovas JM
    Am J Clin Nutr; 2009 Jan; 89(1):391-9. PubMed ID: 19056598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of low-fat meal and high-fat meal on postprandial lipemic response in non-obese men according to the -1131T>C polymorphism of the apolipoprotein A5 (APOA5) gene (randomized cross-over design).
    Kim JY; Kim OY; Koh SJ; Jang Y; Yun SS; Ordovas JM; Lee JH
    J Am Coll Nutr; 2006 Aug; 25(4):340-7. PubMed ID: 16943456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. APOA5-1131T>C genotype effects on apolipoprotein A5 and triglyceride levels in response to dietary intervention and regular exercise (DIRE) in hypertriglyceridemic subjects.
    Jang Y; Chae JS; Kim OY; Park HJ; Kim JY; Paik JK; Lee SH; Lee JH
    Atherosclerosis; 2010 Aug; 211(2):512-9. PubMed ID: 20392444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of apolipoprotein A-V concentration with apolipoprotein A5 gene -1131T>C polymorphism and fasting triglyceride levels.
    Kim JY; Kim OY; Paik JK; Lee SH; Lee JH
    J Clin Lipidol; 2013; 7(2):94-101. PubMed ID: 23415427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender-modulated impact of apolipoprotein A5 gene (APOA5) -1131T>C and c.56C>G polymorphisms on lipids, dyslipidemia and metabolic syndrome in Turkish adults.
    Komurcu-Bayrak E; Onat A; Poda M; Humphries SE; Palmen J; Guclu F; Can G; Erginel-Unaltuna N
    Clin Chem Lab Med; 2008; 46(6):778-84. PubMed ID: 18601598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The apolipoprotein A5 -1131T>C promoter polymorphism in Koreans: association with plasma APOA5 and serum triglyceride concentrations, LDL particle size and coronary artery disease.
    Jang Y; Paik JK; Hyun YJ; Chae JS; Kim JY; Choi JR; Lee SH; Shin DJ; Ordovas JM; Lee JH
    Clin Chim Acta; 2009 Apr; 402(1-2):83-7. PubMed ID: 19159622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. APOA5 gene variation interacts with dietary fat intake to modulate obesity and circulating triglycerides in a Mediterranean population.
    Sánchez-Moreno C; Ordovás JM; Smith CE; Baraza JC; Lee YC; Garaulet M
    J Nutr; 2011 Mar; 141(3):380-5. PubMed ID: 21209257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of high-calorie meal consumption on oxidative stress and endothelial dysfunction in healthy male adults.
    Kackov S; Simundic AM; Nikolac N; Celap I; Dukic L; Ruzic D; Bilusic M
    Physiol Res; 2013; 62(6):643-52. PubMed ID: 23869888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fenofibrate therapy ameliorates fasting and postprandial lipoproteinemia, oxidative stress, and the inflammatory response in subjects with hypertriglyceridemia and the metabolic syndrome.
    Rosenson RS; Wolff DA; Huskin AL; Helenowski IB; Rademaker AW
    Diabetes Care; 2007 Aug; 30(8):1945-51. PubMed ID: 17483155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of APOA5 and APOC3 gene polymorphisms with plasma apolipoprotein A5 level in patients with metabolic syndrome.
    Niculescu LS; Vlădică M; Sima AV
    Biochem Biophys Res Commun; 2010 Jan; 391(1):587-91. PubMed ID: 19932084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneous postprandial lipoprotein responses in the metabolic syndrome, and response to fenofibrate therapy.
    Rosenson RS; Helenowski IB; Tangney CC
    Cardiovasc Drugs Ther; 2010 Dec; 24(5-6):439-47. PubMed ID: 20922563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between the distribution of plasma HDL subclasses and the polymorphisms of APOA5 in hypertriglyceridemia.
    Long S; Chen Z; Han Y; Christopher DM; Zhang C; Yang Y; Tian Y
    Clin Biochem; 2013 Jun; 46(9):733-9. PubMed ID: 23499587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dietary intake of n-6 fatty acids modulates effect of apolipoprotein A5 gene on plasma fasting triglycerides, remnant lipoprotein concentrations, and lipoprotein particle size: the Framingham Heart Study.
    Lai CQ; Corella D; Demissie S; Cupples LA; Adiconis X; Zhu Y; Parnell LD; Tucker KL; Ordovas JM
    Circulation; 2006 May; 113(17):2062-70. PubMed ID: 16636175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The -1131T-->C polymorphism in the apolipoprotein A5 gene is associated with postprandial hypertriacylglycerolemia; elevated small, dense LDL concentrations; and oxidative stress in nonobese Korean men.
    Jang Y; Kim JY; Kim OY; Lee JE; Cho H; Ordovas JM; Lee JH
    Am J Clin Nutr; 2004 Oct; 80(4):832-40. PubMed ID: 15447887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. -1131T>C and SW19 polymorphisms in APOA5 gene and lipid levels in type 2 diabetic patients.
    Sóter MO; Gomes KB; Fernandes AP; Carvalho Md; Pinheiro PS; Bosco AA; Silva DD; Sousa MO
    Mol Biol Rep; 2012 Jul; 39(7):7541-8. PubMed ID: 22350263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenetic association of the APOA1/C3/A4/A5 gene cluster and lipid responses to fenofibrate: the genetics of lipid-lowering drugs and diet network study.
    Liu Y; Ordovas JM; Gao G; Province M; Straka RJ; Tsai MY; Lai CQ; Zhang K; Borecki I; Hixson JE; Allison DB; Arnett DK
    Pharmacogenet Genomics; 2009 Feb; 19(2):161-9. PubMed ID: 19057464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of APOA5 gene variants to plasma triglyceride determination and to the response to both fat and glucose tolerance challenges.
    Martin S; Nicaud V; Humphries SE; Talmud PJ;
    Biochim Biophys Acta; 2003 Apr; 1637(3):217-25. PubMed ID: 12697303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fenofibrate reduces fasting and postprandial inflammatory responses among hypertriglyceridemia patients with the metabolic syndrome.
    Rosenson RS; Huskin AL; Wolff DA; Helenowski IB; Rademaker AW
    Atherosclerosis; 2008 Jun; 198(2):381-8. PubMed ID: 18242616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.